top of page
​
  • In vivo confocal microscopy allows non-invasive “optical biopsy” with the visualisation of the morphology and organisation of the cells in depth of the skin. It is useful for doubtful lesions on dermoscopy and to assess the margins of some lesions (i.e. amelanotic melanoma, lentigo maligna).

  • Lentigo maligna (LM) is a slow growing form of melanoma in situ that can be difficult to recognise. LM can resemble a freckle and develops in heavily sun-damaged older skin, especially on the head and neck.

    • Confocal microscopy allows differentiating LM from benign freckles or solar lentigines, avoiding biopsies in cosmetically sensitive areas.

    • It is also useful when there is a suspicious lesion prior to cosmetic procedures to reassure facial pigmented macules are benign.

    • Margin determination of LM can be challenging because it’s frequent amelanotic component (non pigmented area with melanoma cells that extend beyond the pigmentation we see on the skin), therefore there is more frequent local recurrence than other types of melanoma.

    • Confocal microscopy can help delineate the margins before the surgery or to decide the better treatment approach depending on the extent of the lesion.​

Vivascope for Confocal Microscopy
Confocal Microscopy clinic at Sydney Melanoma Diagnostic Centre
Confocal imaging of suspicious area
Confocal imaging of suspicious lesion
Vivascope for Confocal Microscopy
Professor Pascale Guitera Confocal microscopy imaging
Lentigo maligna
Confocal Microscopy imaging

Confocal Microscopy

Vivascope probe for Confocal Microscopy

Ph:  02 9515 8537 (Mon-Thurs)

        02 8005 4701 (Fri until 1pm)

Fax: 02 9515 5278

Email: info@melanoma.net.au

Our Address:

Sydney Melanoma Diagnostic Centre

Level 2, Gloucester House
Royal Prince Alfred Hospital, Missenden Rd

Camperdown NSW 2050, Australia

​

Quick Links
Our Partners

Affiliated with Cancer Services SLHD

Royal Prince Alfred Hospital
Royal Prince Alfred Hospital
NSW Health
Melanoma Institute Australia

© Sydney Melanoma Diagnostic Center 2009-2020

bottom of page